Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Core Scientific (CORZ) EBIT (2020 - 2026)

Core Scientific has reported EBIT over the past 7 years, most recently at -$310.4 million for Q1 2026.

  • Quarterly results put EBIT at -$310.4 million for Q1 2026, down 559.94% from a year ago — trailing twelve months through Mar 2026 was -$509.0 million (down 108.31% YoY), and the annual figure for FY2025 was -$245.6 million, down 72.87%.
  • EBIT reached -$310.4 million in Q1 2026 per CORZ's latest filing, down from -$117.5 million in the prior quarter.
  • Across five years, EBIT topped out at $55.2 million in Q1 2024 and bottomed at -$1.0 billion in Q2 2022.
  • Median EBIT over the past 5 years was -$47.0 million (2025), compared with a mean of -$164.6 million.
  • The largest annual shift saw EBIT plummeted 8489.92% in 2022 before it surged 626.48% in 2024.
  • Over 5 years, EBIT stood at -$636.1 million in 2022, then skyrocketed by 100.62% to $3.9 million in 2023, then plummeted by 1762.2% to -$65.4 million in 2024, then tumbled by 79.65% to -$117.5 million in 2025, then plummeted by 164.25% to -$310.4 million in 2026.
  • Business Quant data shows EBIT for CORZ at -$310.4 million in Q1 2026, -$117.5 million in Q4 2025, and -$54.8 million in Q3 2025.